News & Articles

New Yumizen G coagulation analyzers and reagent range designed to suit any laboratory

SelectScience brings you scientific and technical takeaways from the 2018 AACR Annual Meeting

Which new product, instrument or consumable has made the most difference to your clinical lab or point-of-care practice? Nominate now for a chance to win a $500/£400/450€ Amazon voucher

The new system aims to deliver fast, accurate results through near native-state cellular characterization, precise flagging and a 93% first-pass throughput

The robust, easy-to-use system aims to boost patient care by combining many of the analytic strengths of a larger-volume instrument with the ease of a table-top analyzer

Prostate health index (phi) test to be exhibited at the AUA annual meeting in San Francisco

First-of-its-kind hematology-based test intended to alert emergency department clinicians to the risk of developing sepsis

Discover the cutting-edge ways science and technology are taking on infectious diseases to help make the future healthier

Healthcare wearables company, Activinsights, commended for enterprise in Britain’s top business accolade

The test will expand the range of diagnostic options available to guide the treatment of Plasmodium vivax

The personal genomics product will focus on 59 genes identified by the American College of Medical Genetics and Genomics

Access Sensitive Estradiol assay aims to provide a better operational efficiency while delivering quality results

Long-term agreement helps ensure a safe and efficient blood supply in the Netherlands

AACR and CRUK, two of the biggest cancer research committees around the globe to join force to aid the development of cancer therapeutics

The AACR and the UBS oncology impact fund aim to use the new funding gift program to propel breakthroughs in cancer research and therapeutics

Metafora biosystems receives exceptional reimbursement for the new METAglut1 test to help diagnose De Vivo disease

New Synapsys microbiology informatics solution will be demonstrated at the event

SelectScience to host a free, educational webinar on the rapid diagnosis of venous thromboembolism

NYU school of medicine becomes the most recent cancer center to join PanFAM-1 prospective study